A multicenter phase I study evaluating dual PI3K and BRAF...

  • Main
  • 2017 / 10
  • A multicenter phase I study evaluating dual PI3K and BRAF...
Clinical Cancer Research 2017 / 10

A multicenter phase I study evaluating dual PI3K and BRAF inhibition with PX-866 and vemurafenib in patients with advanced BRAF V600 mutant solid tumors

Yam, Clinton, Xu, Xiaowei, Davies, Michael A., Gimotty, Phyllis A., Morrissette, Jennifer JD, Tetzlaff, Michael T., Wani, Khalida, Liu, Shujing, Deng, Wanleng, Buckley, Meghan, Zhao, Jianhua, Amaravad
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-17-1807
Date:
October, 2017
File:
PDF, 1.12 MB
english, 2017
Conversion to is in progress
Conversion to is failed